Data is Key to COVID-19 Contact Tracing and Syndromic Surveillance
As the country gradually reopens and people begin returning to work and school, health officials and local leaders must remain vigilant in monitoring the spread of COVID-19. However, tracking procedures which could aid in that effort, such as contact tracing and syndromic surveillance, have been hampered by the inefficient exchange of testing data between healthcare organizations and officials at the local, state, and federal levels.
Dr. Jonathan Teich, Chief Information Medical Officer at InterSystems, spoke with Dr. Bob Kaiser, Clinical Professor at Naveen Jindal School of Management, UT Dallas, about the role of data in producing accurate contact tracing and syndromic surveillance initiatives and how streamlining the exchange of electronic health records will improve patient outcomes in the wake of COVID-19. Tune in to this episode of The Business of Healthcare podcast to learn more.
Originally posted on August 6, 2020. The Business of Healthcare, Episode 68: Contact Tracing and Other Pandemic Data.
InterSystems is the information engine that powers some of the world’s most important applications. In healthcare, business, government, and other sectors where lives and livelihoods are at stake, InterSystems has been a strategic technology provider since 1978. InterSystems is a privately held company headquartered in Cambridge, Massachusetts (USA), with offices worldwide, and its software products are used daily by millions of people in more than 80 countries.